Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin Versus Clopidogrel for Secondary Prevention of Atherosclerotic Cardiovascular Events in Patients With Chronic Coronary Syndrome in the Arabian Gulf Countries: A Randomized, Open-label, Multi-Center Trial by the Gulf Trialists' Collaboration

NCT07572747 is registered in ClinicalTrials.gov with Khalid F Alhabib as lead sponsor.

NCT NCT07572747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07572747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin Versus Clopidogrel for Secondary Prevention of Atherosclerotic Cardiovascular Events in Patients With Chronic Coronary Syndrome in the Arabian Gulf Countries: A Randomized, Open-label, Multi-Center Trial by the Gulf Trialists' Collaboration
Lead sponsor
Khalid F Alhabib
Phase
Phase 3
Overall status
Not yet recruiting
Start date
April 1, 2027
Completion date
April 1, 2032
Enrollment
6,740 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic coronary syndrome